Mirae Asset Global Investments’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
CM
Mirae Asset Global Investments's HRMY Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Harmony Biosciences (HRMY) stake by 14% in Q2 2026, selling an estimated $13.5K and leaving 2,589 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.
Mirae Asset Global Investments first reported a position in HRMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $704K in Q4 2022. 120 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- Mirae Asset Global Investments held 2,589 shares of Harmony Biosciences worth $94.3K as of Q2 2026.
- Mirae Asset Global Investments sold 428 Harmony Biosciences shares in Q2 2026, an estimated $13.5K.
- Harmony Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1247 holding.
- Mirae Asset Global Investments first reported a position in Harmony Biosciences in Q3 2022 and has held it in 16 quarters since.
- Mirae Asset Global Investments's Harmony Biosciences position peaked at $704K in Q4 2022.
- 120 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.